Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
In Vitro Evaluation of Cross-Strain Inhibitory Effects of Igy Polyclonal Antibody Against H. Pylori Publisher Pubmed



Solhi R1 ; Alebouyeh M2 ; Khafri A3 ; Rezaeifard M1 ; Aminian M1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Foodborne and Waterborne Diseases Research Center, Gastroenterology and Liver Diseases Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Quality Control of Bacterial Vaccine Department, Quality Control Management, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran
  4. 4. Recombinant Vaccine Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Microbial Pathogenesis Published:2017


Abstract

The present study aimed to evaluate in vitro cross-strain inhibitory effects of IgY polyclonal antibody on both growth and urease enzyme of four local strains of H. pylori. Leghorn chickens were immunized with whole cells of four different strains of H. pylori, separately. Rising of specific IgY was detected by ELISA. The IgY purified using polyethylene glycol method and the purity was evaluated by SDS-PAGE and Western blotting. Each strain was treated with its own-specific and also other strain-specific IgYs. The strain-specific IgY could inhibit the growth of specific strains by 49–72% and also other different strains of H. pylori by 29–86%. Our findings revealed that strain-specific IgY could inhibit urease activity of its own by 64–72% and other different strains by 49–79%. These findings confirmed strain-specific and also cross-strain inhibitory effects of the IgY polyclonal antibody on both growth and urease activity of H. pylori. © 2017 Elsevier Ltd
Related Docs
1. Production of Igy Polyclonal Antibody Against Diphtheria Toxin and Evaluation of Its Neutralization Effect by Vero Cell Assay, BMC Biotechnology (2021)
2. The Potential Use of Antibiotics Against Helicobacter Pylori Infection: Biopharmaceutical Implications, Frontiers in Pharmacology (2022)
3. Production of Anti-Tetanus Toxin Igy and Study of Its Protective Effects in a Mouse Model, Journal of Immunoassay and Immunochemistry (2023)
Experts (# of related papers)
View all Related Experts
Mahdi Aminian (2)
Mazda Radmalekshahi (1)